Infirmary Otolaryngology Assoc New York City, NY - 10003

Infirmary Otolaryngology Assoc is categorized under Doctors in New York City, NY and active since 2010.

Infirmary Otolaryngology Assoc was established in 2010, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Dan Mui, Administrator at the company’s single location by writing to 310 East 14th St, New York City, New York NY 10003 or by phoning (212) 979-4200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Infirmary Otolaryngology Assoc
Contact Person: Dan Mui, Administrator
Address: 310 East 14th St, New York City, New York 10003
Phone Number: (212) 979-4200
Website Address: nyee.edu
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Infirmary Otolaryngology Assoc was started in 2010 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Dan Mui, Administrator for inquiries that concern Infirmary Otolaryngology Assoc by calling the company number (212) 979-4200, as your correspondence is most welcome. Additionally, the physical location of the single location of Infirmary Otolaryngology Assoc can be found at the coordinates 40.731818,-73.983808 as well as the street address 310 East 14th St in New York City, New York 10003.

For its online presence, you may visit Infirmary Otolaryngology Assoc’s website at nyee.edu and engage with its social media outlets through on Twitter and on Facebook.